Invention Grant
- Patent Title: GSK-3β inhibitor
- Patent Title (中): GSK-3β抑制剂
-
Application No.: US12309906Application Date: 2007-08-02
-
Publication No.: US08492378B2Publication Date: 2013-07-23
- Inventor: Fumio Itoh , Jun Kunitomo , Hiromi Kobayashi , Eiji Kimura , Morihisa Saitoh , Tomohiro Kawamoto , Hiroki Iwashita , Katsuhito Murase
- Applicant: Fumio Itoh , Jun Kunitomo , Hiromi Kobayashi , Eiji Kimura , Morihisa Saitoh , Tomohiro Kawamoto , Hiroki Iwashita , Katsuhito Murase
- Applicant Address: JP Osaka
- Assignee: Takeda Pharmaceutical Company Limited
- Current Assignee: Takeda Pharmaceutical Company Limited
- Current Assignee Address: JP Osaka
- Agency: Wenderoth, Lind & Ponack, L.L.P.
- Priority: JP2006-212642 20060803
- International Application: PCT/JP2007/065203 WO 20070802
- International Announcement: WO2008/016123 WO 20080207
- Main IPC: A61K31/535
- IPC: A61K31/535
Abstract:
For the purpose of providing a GSK-3β inhibitor containing an oxadiazole compound or a salt thereof or a prodrug thereof useful as an agent for the prophylaxis or treatment of a GSK-3β-related pathology or disease, the present invention provides a GSK-3β inhibitor containing a compound represented by the formula (I): wherein each symbol is as defined in the specification, or a salt thereof or a prodrug thereof.
Public/Granted literature
- US20100069381A1 GSK-3BETAINHIBITOR Public/Granted day:2010-03-18
Information query
